Navigation Links
Bioheart, Inc. Announces Financial Results for First Quarter 2008

rt failure.

-- Bioheart initiated its patient registry clinical trial protocol for

MyoCell with MyoCath(R) Injection Catheter delivery in Korea, Singapore

and Switzerland, adding to the number of patients enrolled and

commitment to purchase Bioheart catheters for research purposes.

Other Business Highlights

-- On March 17, 2008, the Company was awarded a U.S. Patent for a method

to repair damaged myocardium (heart tissue) by a combination of cell

transplantation and electrostimulation. The award of this patent brings

to more than 100 the number of related patents and patents pending to

which the Company holds rights. The patent covers methods for repairing

damaged heart tissue by providing electrostimulation to patient-derived

myogenic cells either in the laboratory, while the cells are expanding,

or after the cells are implanted into the damaged areas of the

patient's heart.

-- The May 2008 issue of Cath Lab Digest featured an article on MyoCell

Therapy and the SEISMIC Trial and an interview with Warren Sherman, MD,

Director, Cardiac Cell-based Endovascular Therapies, Columbia

University Medical Center, New York, New York and Principal

Investigator of the MYOHEART Trial and the Phase II/III MARVEL Trial.

Revenues for the quarter ended March 31, 2008 increased to $25,995 compared to $13,805 in first quarter of 2007. During the quarter, we also recognized $61,500 of development revenue for services performed under a clinical registry agreement. The Company reported a net loss for the first quarter of 2008 of $3.3 million, or $(0.24) per share, compared to a net loss of $2.3 million, or $(0.18) per share, for the same quarter last year. The increase in the Company's net loss in the first quarter of 2008 as compared to the first quarter of 2007 is primarily attributable to increased interest expense r

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
(Date:8/20/2014)... often have it that American Indians largely were wiped ... influenza and tuberculosis brought to the New World by ... 20 million people lived in the Americas shortly before ... killed by European diseases., But new research led by ... Johannes Krause of the University of Tubingen in Germany ...
(Date:8/20/2014)... Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: ... presenting at the Baird Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... Wednesday, Sept. 3, 2014. A live webcast ... section of PAREXEL,s website at in ...
(Date:8/20/2014)... 20, 2014 WriteResult®, a leading provider ... it has expanded its myPROpad™ ePRO tablet with the ... one of the most widely used and well-respected Patient ... status. The EQ-5D is used during clinical trials and ... that can be used to demonstrate Health-Related Quality of ...
(Date:8/19/2014)... , Aug. 19, 2014 A Geisinger researcher ... nominated for a Centers for Disease Control and Prevention ... major public health concern. Joseph Boscarino ... one of a team of researchers nominated for the ... Shepard Science Award for Data Methods and Study Design. ...
Breaking Biology Technology:Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3PAREXEL International To Present At Baird Healthcare Conference 2EQ-5D™ Assessment Now Available for iPad 2Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3
... Nanotechnologies (PEN) has developed findNano, an application for ... discover and determine whether consumer products are nanotechnology-enabled. ... engineering them at an incredibly small scale, has ... delivery systems. findNano allows users ...
... , CORAL GABLES, Fla., Nov. 13 Catalyst Pharmaceutical ... Nasdaq Staff Deficiency Letter dated November 13, 2009 indicating that ... Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for ... Nasdaq Listing Rules (the "Rules") require listed securities to maintain ...
... TAI,AN CITY, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- China ... the "Company"),one of the leading plasma-based pharmaceutical companies in ... call at 8:00 a.m. ET on,Monday, November 16, 2009, ... September 30, 2009. , Hosting ...
Cached Biology Technology:findNano app puts nanotech in your pocket 2Catalyst Receives Guidance from Nasdaq Regarding Minimum Bid Price Requirement 2China Biologic Schedules Conference Call to Discuss Third Quarter 2009 Financial Results 2
(Date:8/20/2014)... rugs and plastic bags could one day be made ... petroleum, scientists are now reporting. The novel process they ... deal with its agricultural and plastic waste problems, appear ... Athanassiou, Ilker S. Bayer and colleagues at the Italian ... constantly growing. In 2012, its production reached 288 million ...
(Date:8/20/2014)... for electronically manipulating the flight muscles of moths and ... those muscles. The work opens the door to the ... emergency response. , "In the big picture, we want ... moths for use in applications such as search and ... of electrical and computer engineering at NC State and ...
(Date:8/19/2014)... decrease China,s increasing caesarean section rate, suggests a new ... International Journal of Obstetrics and Gynaecology (BJOG) . , ... in the world. Of 16 million babies born in ... rate is not known, the current Chinese language literature ... ranging from 36% to 58%. However, before the 1980s, ...
Breaking Biology News(10 mins):Research paves way for development of cyborg moth 'biobots' 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3
... A multi-disciplinary 5-year project at the University of ... has received $10 million in funding from the National ... and eventually manipulate the communication between cells that causes ... the School of Medicine, the College of Science and ...
... article in the Journal of Integrated Pest Management ... and present management practices, and current research being conducted. ... an introduced insect pest of small grains first recorded in ... from Europe or Asia into Michigan, cereal leaf beetle has ...
... REDWOOD CITY, Calif., Oct. 17, 2011 ... will address critical issues surrounding the use of biometrics for ... market update on October 19, 2011 at 11:05 a.m. GMT, ... On October 20, 2011 at 11:15 a.m. GMT, Bjorn will ...
Cached Biology News:$10 million grant supports biological sciences team at University of Nevada, Reno 2$10 million grant supports biological sciences team at University of Nevada, Reno 3DigitalPersona Co-Founder and CTO to Tackle Critical Issue of Civil ID Security at Biometrics 2011 2
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Dendritic Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Biology Products: